Table 1 Characteristics of participants at Baseline.

From: Nonlinear dose-response relationship between red blood cell distribution width to platelet ratio and 90-day unfavorable outcomes in acute ischemic stroke: a prospective cohort study

RPR quartiles

Q1(<0.14)

Q2(0.14–0.18)

Q3(0.18–0.23)

Q4(≥ 0.23)

P-value

N

421

420

420

421

 

Neu (109/L, mean ± SD)

5.84 ± 2.72

5.83 ± 2.83

5.04 ± 2.27

5.57 ± 3.36

< 0.001

Lyc (109/L, mean ± SD)

1.66 ± 0.66

1.89 ± 0.70

1.59 ± 0.61

1.43 ± 0.61

< 0.001

NIHSS score (median, quartile)

4.02(2.00–8.00)

4.10 (2.00–8.00)

4.09 (2.00–8.03.00.03)

4.30 (2.09–8.15)

0.676

HGB (g/L, mean ± SD)

140.07 ± 19.02

140.36 ± 18.61

137.76 ± 21.48

137.71 ± 22.63

0.102

BMI (kg/m2, mean ± SD)

21.78 ± 3.25

22.60 ± 3.42

23.52 ± 3.10

24.28 ± 3.26

0.017

RDW (fl., mean ± SD)

33.70 (22.80–39.00)

41.30 (39.70–43.60)

42.50 (40.60–44.70)

44.80 (42.30–47.80)

< 0.001

Platele (109/L, mean ± SD)

262.87 ± 102.51

259.47 ± 33.92

210.62 ± 22.78

151.12 ± 28.69

< 0.001

FIB (g/L, mean ± SD)

3.03 ± 1.43

3.36 ± 1.27

3.32 ± 1.31

3.23 ± 1.47

0.002

HCY (umol/L, mean ± SD)

14.40 (10.46–21.00.46.00)

12.90 (9.88–17.52)

13.14 (9.80–18.62.80.62)

14.00 (11.00–20.82.00.82)

0.104

ALB(g/L, mean ± SD)

38.16 ± 4.25

37.64 ± 4.22

37.34 ± 5.46

36.50 ± 4.73

< 0.001

FPG(mmol/L, mean ± SD)

6.54 ± 2.81

7.27 ± 2.90

6.86 ± 3.07

6.70 ± 2.90

0.008

TC (mmol/L, mean ± SD)

4.71 ± 1.26

4.64 ± 1.49

4.70 ± 4.66

4.37 ± 1.21

0.196

TG (mmol/L, mean ± SD)

1.45 (1.04–2.04)

1.47 (1.01–2.00.01.00)

1.35 (1.05–1.95)

1.23 (0.90–1.76)

< 0.001

HDL-c(mmol/L, median, quartile)

1.07 (0.91–1.28)

1.21 (1.02–1.43)

1.16 (0.99–1.37)

1.19 (0.99–1.43)

0.354

LDL-c(mmol/L, mean ± SD)

3.03 ± 0.96

3.10 ± 1.02

2.97 ± 1.01

2.82 ± 0.90

< 0.001

Age (years, mean ± SD)

66.29 ± 11.27

64.57 ± 11.12

68.29 ± 10.92

71.49 ± 10.94

< 0.001

D-dimer(mg/dL, mean ± SD)

1.36 (0.58–3.28)

0.65 (0.49–1.66)

0.75 (0.49–2.05)

1.31 (0.63–4.18)

< 0.001

SEX

    

0.010

Male

244 (57.96%)

250 (59.52%)

273 (65.00%)

285 (67.70%)

 

Female

177 (42.04%)

170 (40.48%)

147 (35.00%)

136 (32.30%)

 

Previous stroke/TIA (n, %)

30 (7.13%)

40 (9.52%)

37 (8.81%)

33 (7.84%)

0.605

DM (n, %)

122 (28.98%)

136 (32.38%)

129 (30.71%)

109 (25.89%)

0.198

Hypertension (n, %)

261 (62.00%)

223 (53.10%)

247 (58.81%)

222 (52.73%)

0.015

CHD (n, %)

92 (21.85%)

66 (15.71%)

88 (20.95%)

128 (30.40%)

< 0.001

AF (n, %)

45 (10.69%)

25 (5.95%)

42 (10.00%)

74 (17.58%)

< 0.001

Pneumonia (n, %)

50 (11.88%)

65 (15.48%)

60 (14.29%)

98 (23.28%)

< 0.001

Smoking (n, %)

48 (11.40%)

74(17.62%)

103 (24.52%)

121 (28.74%)

< 0.001

Stroke etiology (n, %)

    

0.327

SVO

135 (32.07%)

146 (34.76%)

138 (32.86%)

137 (32.54%)

 

LAA

73 (17.34%)

95 (22.62%)

75 (17.86%)

96 (22.80%)

 

CE

112 (26.60%)

91 (21.67%)

114 (27.14%)

94 (22.33%)

 

Other determined

41 (9.74%)

26 (6.19%)

34 (8.10%)

35 (8.31%)

 

Undetermined

60 (14.25%)

62 (14.76%)

59 (14.05%)

59 (14.01%)

 
  1. Values are mean ± standard deviation or median (interquartile) or number (%) NEU, neutrophil count; CHD, coronary heart disease; HDL-c, high-density lipoprotein cholesterol; LYC, lymphocyte count; FPG, fasting plasma glucose; BMI, body mass index; FIB, fibrinogen; SVO, small vessel occlusion; HCY, homocysteine; TC, total cholesterol; ALB, serum albumin; HGB, hemoglobin concentration; TG, triglycerides; DM, diabetes mellitus; LAA, large artery atherosclerosis; LDL-C, low-density lipoprotein cholesterol; TIA, transient ischemia attack; NIHSS, National Institute of Health stroke scale; AF, atrial fibrillation; CE, cardio embolism; N, Number.
Back to article page